Morphic (MORF) Company Total Revenue

The market value of Morphic Holding, Inc. (MORF) already prices in an acquisition by a tech giant following successful drug trials. A team of top biologists is developing breakthrough integrin therapy supported by generous funding. The company's aggregate sales level, as reported by GURU.Markets, reflects a trend where the 0.00 metric confirms the current level. Operational stability is based on the contract manufacturing of oral medications in the US.

Morphic Therapeutic (MORF) - Company Revenue from 07/04/2022 to 08/24/2024

Comprehensive metric breakdowns and analytics for Morphic Holding Corp (MORF)

- stock value and consensus price forecast:

Stock Quotes morphictx.com|MORF - Price Target Chart

- market capitalization details:

Market Value Morphic Holding Inc|MORF - Total Company Value

- book value of equity indicators:

Accounting Value of a Share Morphic|MORF - Company Book Value|Market Capitalization to Net Assets morphictx.com|MORF - Company Total Assets

- company liabilities and liquidity data:

All Debt to Shareholders' Equity Ratio Morphic Holding, Inc.|MORF - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Morphic Holding Inc|MORF - Company Aggregate Debts|Debt to Book Value Morphic Holding Corp|MORF - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Morphic|Intermediate Coverage Ratio morphictx.com

- earnings and valuation multiples indicators:

MORF - Company Net Income|Expected Net Profit Morphic Holding, Inc.|MORF - Price to Earnings Ratio|Future Price to Earnings Morphic|MORF - PEG Multiple|Enterprise Value to Operating Income Before Depreciation Morphic Holding, Inc.|MORF - Operating profit EBITDA|Net earnings per share for the last four quarters Morphic|MORF - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months morphictx.com|MORF - Earnings growth in current year|Net earnings per one share growth forecast for next year Morphic Holding, Inc.

- sales volume and revenue indicators:

MORF - Company Sales|Company Future Revenue Morphic Holding, Inc.|MORF - P/S Multiple|Market Cap to Expected Sales Ratio Morphic Holding Inc

Summary company analysis:MORF Morphic

Flagship merchandise of Morphic Holding Inc

This indicator determines the investment reliability of Morphic Holding, Inc. (MORF) by tracking daily cash inflows from product sales to assess the actual execution of business plans. By analyzing the company's sales trend, an investor can observe revenue stability, which, in the non-cyclical biotech sector of GI and vascular drug development, is supported by constant demand for chronic disease therapies.

Competing companies